TSHR and autoimmune thyroid disease: As autoreactive B cells producing autoantibodies against TSHR are a major pathogenetic feature of autoimmune thyroiditis and TED,23 we expectedly detected increased B cell abundance and upregulated expression of immunoglobulin genes in TED tissues compared with controls, further supporting the rationale for anti-CD20 therapy in TED.